Drug
trastuzumab and hyaluronidase-oysk
Marketed as HERCEPTIN HYLECTA.
Generic name
trastuzumab and hyaluronidase-oysk
Brand names
HERCEPTIN HYLECTA
First FDA approval
2019-02-28
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761106 | HERCEPTIN HYLECTA | 2019-02-28 | GENENTECH INC |
Manufacturers
GENENTECH INC
Frequently asked questions
When was trastuzumab and hyaluronidase-oysk FDA approved?
Earliest FDA approval on record: 2019-02-28.
What brand names are sold as trastuzumab and hyaluronidase-oysk?
HERCEPTIN HYLECTA.
Sources
Appeal a trastuzumab and hyaluronidase-oysk denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com